Concepedia

Sony Sotelo Rocha

SS

Statistics

Publications

4

Citations

274

H-Index

4

Active since

2018

Affiliations

Rapt Therapeutics (United States)(Current)

Sony Sotelo Rocha is an author at Rapt Therapeutics (United States) specializing in oncology, cancer immunology, and immunology.

ORCID

Publications per year

2018–2024

4

Publications

4

ALX148 blocks CD47 and enhances innate and adaptive antitumor immunity with a favorable safety profile

Steven E. Kauder, Tracy C. Kuo, Ons Harrabi et al. · PLoS ONE · 2018 · 171 citations · Full text

, , +17

TriTACs, a Novel Class of T-Cell–Engaging Protein Constructs Designed for the Treatment of Solid Tumors

Richard J. Austin, Bryan D. Lemon, Wade H. Aaron et al. · Molecular Cancer Therapeutics · 2020 · 64 citations · Full text

, , +17

HPN328, a Trispecific T Cell–Activating Protein Construct Targeting DLL3-Expressing Solid Tumors

Mary E. Molloy, Wade H. Aaron, Manasi Barath et al. · Molecular Cancer Therapeutics · 2024 · 29 citations · Full text

, , +17

Abstract 933: ProTriTAC is a modular and robust T cell engager prodrug platform with therapeutic index expansion observed across multiple tumor targets

Sen Lin, Sony Sotelo Rocha, Kathryn Kwant et al. · Cancer Research · 2021 · 10 citations

, , +17

1–4 of 4